Shaan Syed Khurshid, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 35 | 2024 | 5127 | 3.990 |
Why?
|
Electrocardiography | 17 | 2024 | 6377 | 2.760 |
Why?
|
Cardiomyopathies | 10 | 2023 | 1964 | 2.370 |
Why?
|
Stroke | 15 | 2024 | 9757 | 1.160 |
Why?
|
Artificial Intelligence | 6 | 2024 | 2578 | 1.110 |
Why?
|
Ventricular Dysfunction, Left | 3 | 2023 | 2118 | 1.010 |
Why?
|
Pacemaker, Artificial | 2 | 2023 | 807 | 0.880 |
Why?
|
Cardiac Pacing, Artificial | 4 | 2023 | 866 | 0.880 |
Why?
|
Heart Ventricles | 5 | 2023 | 3807 | 0.710 |
Why?
|
Brugada Syndrome | 1 | 2021 | 93 | 0.700 |
Why?
|
Arrhythmias, Cardiac | 3 | 2024 | 2244 | 0.690 |
Why?
|
Atrial Flutter | 1 | 2022 | 252 | 0.690 |
Why?
|
Cardiovascular System | 2 | 2024 | 834 | 0.670 |
Why?
|
Models, Cardiovascular | 2 | 2022 | 981 | 0.660 |
Why?
|
Electrocardiography, Ambulatory | 2 | 2022 | 578 | 0.650 |
Why?
|
Exercise | 3 | 2024 | 5890 | 0.620 |
Why?
|
Heart Conduction System | 3 | 2023 | 1007 | 0.620 |
Why?
|
Electric Countershock | 1 | 2021 | 533 | 0.610 |
Why?
|
Perceptual Disorders | 2 | 2011 | 198 | 0.600 |
Why?
|
Risk Assessment | 16 | 2024 | 23995 | 0.580 |
Why?
|
Cryosurgery | 1 | 2022 | 474 | 0.560 |
Why?
|
Cardiac Resynchronization Therapy Devices | 1 | 2017 | 122 | 0.540 |
Why?
|
Electric Stimulation Therapy | 1 | 2022 | 628 | 0.520 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2021 | 851 | 0.510 |
Why?
|
Ventricular Function, Left | 7 | 2023 | 3879 | 0.510 |
Why?
|
Phenethylamines | 1 | 2015 | 95 | 0.480 |
Why?
|
Ventricular Function, Right | 3 | 2023 | 617 | 0.480 |
Why?
|
Heart Failure | 9 | 2024 | 11669 | 0.470 |
Why?
|
Incidence | 13 | 2024 | 21353 | 0.460 |
Why?
|
Quality Indicators, Health Care | 1 | 2024 | 1792 | 0.450 |
Why?
|
Defibrillators, Implantable | 2 | 2021 | 1490 | 0.450 |
Why?
|
Cardiac Resynchronization Therapy | 1 | 2017 | 555 | 0.380 |
Why?
|
Risk Factors | 22 | 2024 | 74206 | 0.380 |
Why?
|
Models, Genetic | 1 | 2021 | 3442 | 0.380 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1998 | 0.370 |
Why?
|
Middle Aged | 36 | 2024 | 220895 | 0.360 |
Why?
|
Catheter Ablation | 2 | 2022 | 2751 | 0.360 |
Why?
|
Anti-Arrhythmia Agents | 1 | 2015 | 774 | 0.360 |
Why?
|
Anticoagulants | 4 | 2020 | 4812 | 0.350 |
Why?
|
Humans | 69 | 2024 | 761504 | 0.350 |
Why?
|
Electronic Health Records | 7 | 2024 | 4811 | 0.340 |
Why?
|
Genome-Wide Association Study | 9 | 2024 | 12690 | 0.340 |
Why?
|
Reperfusion | 1 | 2011 | 271 | 0.340 |
Why?
|
Mass Screening | 4 | 2024 | 5428 | 0.330 |
Why?
|
Male | 42 | 2024 | 360804 | 0.320 |
Why?
|
Aged | 31 | 2024 | 169289 | 0.320 |
Why?
|
Vision, Monocular | 1 | 2009 | 71 | 0.310 |
Why?
|
Predictive Value of Tests | 8 | 2024 | 15266 | 0.310 |
Why?
|
Bradycardia | 2 | 2022 | 299 | 0.310 |
Why?
|
Female | 38 | 2024 | 392644 | 0.280 |
Why?
|
Brain Ischemia | 1 | 2020 | 3049 | 0.270 |
Why?
|
Cardiovascular Diseases | 5 | 2024 | 15500 | 0.260 |
Why?
|
Aorta | 2 | 2024 | 2042 | 0.260 |
Why?
|
Algorithms | 6 | 2024 | 14031 | 0.250 |
Why?
|
Time Factors | 7 | 2024 | 39967 | 0.250 |
Why?
|
Sulfonamides | 1 | 2015 | 1978 | 0.240 |
Why?
|
Heart | 5 | 2024 | 4404 | 0.240 |
Why?
|
Stroke Volume | 6 | 2024 | 5496 | 0.240 |
Why?
|
Heart Rate | 3 | 2024 | 4195 | 0.230 |
Why?
|
Apolipoprotein B-100 | 1 | 2024 | 157 | 0.230 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 1 | 2023 | 162 | 0.200 |
Why?
|
Prostheses and Implants | 1 | 2009 | 1271 | 0.200 |
Why?
|
Receptors, LDL | 1 | 2024 | 488 | 0.190 |
Why?
|
Age Factors | 5 | 2024 | 18395 | 0.190 |
Why?
|
Aged, 80 and over | 12 | 2022 | 58976 | 0.190 |
Why?
|
Tachycardia, Supraventricular | 1 | 2024 | 273 | 0.190 |
Why?
|
Aortic Aneurysm | 2 | 2022 | 648 | 0.180 |
Why?
|
Cerebrovascular Circulation | 1 | 2011 | 2727 | 0.180 |
Why?
|
Endophenotypes | 1 | 2022 | 255 | 0.180 |
Why?
|
Retrospective Studies | 11 | 2023 | 80636 | 0.180 |
Why?
|
Cost-Benefit Analysis | 3 | 2022 | 5492 | 0.170 |
Why?
|
Action Potentials | 2 | 2018 | 1834 | 0.170 |
Why?
|
Survival Rate | 4 | 2021 | 12725 | 0.160 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 1096 | 0.160 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2022 | 829 | 0.160 |
Why?
|
Tricuspid Valve | 1 | 2022 | 410 | 0.160 |
Why?
|
Prospective Studies | 6 | 2024 | 54425 | 0.160 |
Why?
|
Follow-Up Studies | 7 | 2024 | 39106 | 0.160 |
Why?
|
Treatment Outcome | 6 | 2023 | 64680 | 0.160 |
Why?
|
Attention | 1 | 2009 | 2396 | 0.160 |
Why?
|
Asymptomatic Diseases | 1 | 2021 | 588 | 0.150 |
Why?
|
Prevalence | 3 | 2023 | 15732 | 0.150 |
Why?
|
Ventricular Remodeling | 2 | 2024 | 1267 | 0.150 |
Why?
|
Heart Atria | 1 | 2024 | 1345 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 628 | 0.150 |
Why?
|
Long QT Syndrome | 1 | 2022 | 467 | 0.150 |
Why?
|
Electronic Prescribing | 1 | 2018 | 114 | 0.140 |
Why?
|
Oxygen Consumption | 1 | 2024 | 1866 | 0.140 |
Why?
|
Models, Economic | 1 | 2021 | 716 | 0.140 |
Why?
|
Natural Language Processing | 2 | 2023 | 1162 | 0.140 |
Why?
|
Comparative Effectiveness Research | 1 | 2021 | 709 | 0.130 |
Why?
|
Health Services Misuse | 1 | 2018 | 244 | 0.130 |
Why?
|
Exercise Test | 1 | 2024 | 2127 | 0.130 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2023 | 1050 | 0.130 |
Why?
|
Birth Weight | 1 | 2024 | 2103 | 0.130 |
Why?
|
Intracranial Hemorrhages | 1 | 2021 | 822 | 0.130 |
Why?
|
Echocardiography | 3 | 2022 | 4989 | 0.120 |
Why?
|
Pulse Therapy, Drug | 1 | 2015 | 37 | 0.120 |
Why?
|
Gestational Age | 1 | 2024 | 3577 | 0.120 |
Why?
|
Equipment Design | 1 | 2023 | 3510 | 0.120 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 783 | 0.120 |
Why?
|
Cognition Disorders | 1 | 2009 | 3979 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 1 | 2021 | 1722 | 0.120 |
Why?
|
Fever | 1 | 2022 | 1618 | 0.120 |
Why?
|
Coronary Artery Disease | 2 | 2024 | 6403 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 521 | 0.110 |
Why?
|
Pennsylvania | 1 | 2014 | 613 | 0.100 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3769 | 0.100 |
Why?
|
Administration, Oral | 2 | 2018 | 4021 | 0.100 |
Why?
|
Genetic Predisposition to Disease | 6 | 2024 | 17904 | 0.100 |
Why?
|
Circadian Rhythm | 1 | 2024 | 2576 | 0.100 |
Why?
|
Proportional Hazards Models | 3 | 2019 | 12463 | 0.100 |
Why?
|
Multivariate Analysis | 2 | 2016 | 12059 | 0.100 |
Why?
|
Aortic Valve Stenosis | 1 | 2024 | 2001 | 0.100 |
Why?
|
Primary Health Care | 3 | 2023 | 4686 | 0.100 |
Why?
|
Equipment Failure | 1 | 2014 | 578 | 0.100 |
Why?
|
Adult | 12 | 2024 | 221177 | 0.100 |
Why?
|
Genetic Association Studies | 1 | 2020 | 2735 | 0.090 |
Why?
|
Recovery of Function | 1 | 2021 | 2979 | 0.090 |
Why?
|
Cohort Studies | 4 | 2023 | 41487 | 0.090 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3416 | 0.090 |
Why?
|
Hemorrhage | 2 | 2022 | 3424 | 0.090 |
Why?
|
Public Health | 1 | 2023 | 2669 | 0.080 |
Why?
|
Eye Protective Devices | 1 | 2009 | 33 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2781 | 0.080 |
Why?
|
Recurrence | 3 | 2020 | 8465 | 0.080 |
Why?
|
Spatial Behavior | 1 | 2009 | 88 | 0.080 |
Why?
|
Sensory Deprivation | 1 | 2009 | 108 | 0.080 |
Why?
|
Health Care Costs | 1 | 2021 | 3242 | 0.080 |
Why?
|
Guideline Adherence | 1 | 2018 | 2220 | 0.070 |
Why?
|
Prognosis | 3 | 2024 | 29625 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4028 | 0.070 |
Why?
|
Orientation | 1 | 2009 | 321 | 0.070 |
Why?
|
Neuropsychological Tests | 2 | 2011 | 7045 | 0.070 |
Why?
|
Life Style | 1 | 2018 | 3917 | 0.070 |
Why?
|
Atherosclerosis | 1 | 2022 | 3408 | 0.070 |
Why?
|
Tachycardia, Ventricular | 1 | 2015 | 1304 | 0.070 |
Why?
|
Space Perception | 1 | 2009 | 465 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4671 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10766 | 0.060 |
Why?
|
Severity of Illness Index | 2 | 2015 | 15842 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 9000 | 0.060 |
Why?
|
Photic Stimulation | 1 | 2011 | 1985 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6814 | 0.060 |
Why?
|
Massachusetts | 1 | 2017 | 8830 | 0.060 |
Why?
|
Odds Ratio | 1 | 2016 | 9646 | 0.060 |
Why?
|
Brain | 1 | 2011 | 27112 | 0.060 |
Why?
|
Comorbidity | 1 | 2018 | 10508 | 0.050 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2024 | 148 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2024 | 527 | 0.050 |
Why?
|
Atrial Function, Left | 1 | 2024 | 185 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7390 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2022 | 77 | 0.050 |
Why?
|
Functional Laterality | 1 | 2009 | 2257 | 0.050 |
Why?
|
Myocardial Infarction | 1 | 2023 | 11460 | 0.050 |
Why?
|
Adaptation, Physiological | 1 | 2009 | 1301 | 0.050 |
Why?
|
Body Weights and Measures | 1 | 2022 | 208 | 0.050 |
Why?
|
Visual Fields | 1 | 2009 | 1062 | 0.050 |
Why?
|
Logistic Models | 1 | 2016 | 13255 | 0.050 |
Why?
|
Lamin Type A | 1 | 2022 | 189 | 0.050 |
Why?
|
Hospitalization | 1 | 2021 | 10723 | 0.050 |
Why?
|
Psychomotor Performance | 1 | 2009 | 1881 | 0.050 |
Why?
|
Registries | 3 | 2023 | 8224 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 3 | 2024 | 36426 | 0.040 |
Why?
|
Myocardium | 2 | 2023 | 4726 | 0.040 |
Why?
|
Chronic Disease | 1 | 2015 | 9318 | 0.040 |
Why?
|
United States | 4 | 2021 | 72334 | 0.040 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26125 | 0.040 |
Why?
|
Attitude | 1 | 2023 | 775 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1303 | 0.040 |
Why?
|
Mendelian Randomization Analysis | 1 | 2024 | 1007 | 0.040 |
Why?
|
Automation | 1 | 2020 | 586 | 0.040 |
Why?
|
Longitudinal Studies | 2 | 2024 | 14605 | 0.030 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 696 | 0.030 |
Why?
|
Multifactorial Inheritance | 1 | 2024 | 1387 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2049 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1787 | 0.030 |
Why?
|
Pulmonary Artery | 1 | 2024 | 1927 | 0.030 |
Why?
|
Age of Onset | 1 | 2022 | 3305 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2024 | 2382 | 0.030 |
Why?
|
Genetic Loci | 1 | 2024 | 2632 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 771 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 668 | 0.030 |
Why?
|
Aortic Valve | 1 | 2024 | 1955 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16591 | 0.030 |
Why?
|
Body Surface Potential Mapping | 1 | 2015 | 228 | 0.030 |
Why?
|
Learning | 1 | 2023 | 1740 | 0.030 |
Why?
|
Quantitative Trait Loci | 1 | 2021 | 2116 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1570 | 0.030 |
Why?
|
ROC Curve | 1 | 2020 | 3579 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1027 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2024 | 3245 | 0.020 |
Why?
|
Genetic Variation | 1 | 2024 | 6567 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4618 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1273 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14666 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12974 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 2751 | 0.020 |
Why?
|
Delivery of Health Care | 1 | 2023 | 5336 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10552 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2243 | 0.020 |
Why?
|
Case-Control Studies | 1 | 2023 | 22176 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 7967 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20098 | 0.020 |
Why?
|
Coronary Disease | 1 | 2019 | 5914 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2024 | 15936 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 12953 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2024 | 26198 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8481 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3801 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 9053 | 0.010 |
Why?
|
Hypertension | 1 | 2019 | 8540 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20570 | 0.010 |
Why?
|